SEP 9, 2026 · PHASE 1 TRIAL
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
ClinicalTrials.gov
This is a Phase 1, first-in-human study registration with no results posted; it describes planned enrollment and safety endpoints only, representing early-stage drug development.
Reported
Planned enrollment392
Study phasePhase 1
Primary endpoint 1Determination of maximum tolerated dose (MT…